Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 1
2002 15
2003 21
2004 20
2005 20
2006 16
2007 21
2008 27
2009 38
2010 50
2011 66
2012 66
2013 78
2014 82
2015 96
2016 112
2017 116
2018 113
2019 152
2020 163
2021 184
2022 224
2023 235
2024 104

Text availability

Article attribute

Article type

Publication date

Search Results

1,777 results

Results by year

Filters applied: . Clear all
Page 1
PANoptosis: Mechanisms, biology, and role in disease.
Sun X, Yang Y, Meng X, Li J, Liu X, Liu H. Sun X, et al. Among authors: liu x. Immunol Rev. 2024 Jan;321(1):246-262. doi: 10.1111/imr.13279. Epub 2023 Oct 12. Immunol Rev. 2024. PMID: 37823450 Review.
Peptidoglycan-based immunomodulation.
Sun Q, Liu X, Li X. Sun Q, et al. Among authors: liu x. Appl Microbiol Biotechnol. 2022 Feb;106(3):981-993. doi: 10.1007/s00253-022-11795-4. Epub 2022 Jan 25. Appl Microbiol Biotechnol. 2022. PMID: 35076738 Review.
Magnetic nanomaterials-mediated neuromodulation.
Lu X, Li G, Jiao W, Li K, Zhang T, Liu X, Fan H. Lu X, et al. Among authors: liu x. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 Jul-Aug;15(4):e1890. doi: 10.1002/wnan.1890. Epub 2023 Apr 23. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023. PMID: 37089064 Review.
Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial.
Jiang Q, Li Z, Qin Y, Li W, Xu N, Liu B, Zhang Y, Meng L, Zhu H, Du X, Chen S, Liang Y, Hu Y, Liu X, Song Y, Men L, Chen Z, Niu Q, Wang H, Lu M, Yang D, Zhai Y, Huang X. Jiang Q, et al. Among authors: liu x. J Hematol Oncol. 2022 Aug 18;15(1):113. doi: 10.1186/s13045-022-01334-z. J Hematol Oncol. 2022. PMID: 35982483 Free PMC article. Clinical Trial.
The molecular classification of cancer-associated fibroblasts on a pan-cancer single-cell transcriptional atlas.
Chen B, Chan WN, Xie F, Mui CW, Liu X, Cheung AHK, Lung RWM, Chow C, Zhang Z, Fang C, Yu P, Shi S, Zhou S, Chen G, Wang Z, Wang S, Ding X, Huang B, Liang L, Dong Y, Wong CC, Wu WKK, Cheng ASL, Wong N, Yu J, Lo KW, Tse GMK, Kang W, To KF. Chen B, et al. Among authors: liu x. Clin Transl Med. 2023 Dec;13(12):e1516. doi: 10.1002/ctm2.1516. Clin Transl Med. 2023. PMID: 38148640 Free PMC article.
Cancer-associated fibroblasts potentiate colorectal cancer progression by crosstalk of the IGF2-IGF1R and Hippo-YAP1 signaling pathways.
Zhang J, Chen B, Li H, Wang Y, Liu X, Wong KY, Chan WN, Chan AK, Cheung AH, Leung KT, Dong Y, Pan Y, Ke H, Liang L, Zhou Z, Xiao J, Wong CC, Wu WK, Cheng AS, Ma BB, Yu J, Lo KW, Kang W; Ka Fai To. Zhang J, et al. Among authors: liu x. J Pathol. 2023 Feb;259(2):205-219. doi: 10.1002/path.6033. Epub 2022 Dec 17. J Pathol. 2023. PMID: 36373776
1,777 results